دورية أكاديمية

Translational boron neutron capture therapy (BNCT) studies for the treatment of tumors in lung

التفاصيل البيبلوغرافية
العنوان: Translational boron neutron capture therapy (BNCT) studies for the treatment of tumors in lung
المؤلفون: Trivillin V. A., Serrano A., Garabalino M. A., Colombo L. L., Pozzi E. C., Hughes A. M., Curotto P. M., Thorp S. I., Farias R. O., Gonzalez S. J., Bortolussi S., Altieri S., Itoiz M. E., Aromando R. F., Nigg D. W., Schwint A. E.
المساهمون: Trivillin, V. A., Serrano, A., Garabalino, M. A., Colombo, L. L., Pozzi, E. C., Hughes, A. M., Curotto, P. M., Thorp, S. I., Farias, R. O., Gonzalez, S. J., Bortolussi, S., Altieri, S., Itoiz, M. E., Aromando, R. F., Nigg, D. W., Schwint, A. E.
سنة النشر: 2019
المجموعة: IRIS UNIPV (Università degli studi di Pavia)
مصطلحات موضوعية: BDIX rat, BNCT, BNCT survival studie, Boron neutron capture therapy, colon carcinoma, lung metastase, Animal, Cell Line, Tumor, Colonic Neoplasm, Dose-Response Relationship, Radiation, Lung Neoplasm, Radiometry, Rat, Survival Analysi, Translational Medical Research
الوصف: Purpose: Boron neutron capture therapy (BNCT) combines selective accumulation of 10 B carriers in tumor tissue with subsequent neutron irradiation. BNCT has been proposed for the treatment of multiple, non-resectable, diffuse tumors in lung. The aim of the present study was to evaluate the therapeutic efficacy and toxicity of BNCT in an experimental model of lung metastases of colon carcinoma in BDIX rats and perform complementary survival studies. Materials and methods: We evaluated tumor control and toxicity in lung 2 weeks post-BNCT at 2 dose levels, including 5 experimental groups per dose level: T0 (euthanized pre-treatment), Boronophenylalanine-BNCT (BPA-BNCT), BPA + Sodium decahydrodecaborate-BNCT ((BPA + GB-10)-BNCT), Beam only (BO) and Sham (no treatment, same manipulation). Tumor response was assessed employing macroscopic and microscopic end-points. An additional experiment was performed to evaluate survival and oxygen saturation in blood. Results and conclusions: No dose-limiting signs of short/medium-term toxicity were observed in lung. All end-points revealed statistically significant BNCT-induced tumor control vs Sham at both dose levels. The survival experiment showed a statistically significant 45% increase in post-treatment survival time in the BNCT group (48 days) versus Sham (33 days). These data consistently revealed growth suppression of lung metastases by BNCT with no manifest lung toxicity.Highlights Boron Neutron Capture Therapy suppresses growth of experimental lung metastases No BNCT-induced short/medium-term toxicity in lung is associated with tumor control Boron Neutron Capture Therapy increased post-treatment survival time by 45%.
نوع الوثيقة: article in journal/newspaper
وصف الملف: STAMPA
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30601686; info:eu-repo/semantics/altIdentifier/wos/WOS:000466418600012; volume:95; issue:5; firstpage:646; lastpage:654; numberofpages:9; journal:INTERNATIONAL JOURNAL OF RADIATION BIOLOGY; http://hdl.handle.net/11571/1320766Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85062372778; http://www.tandfonline.com/loi/irab20Test
DOI: 10.1080/09553002.2019.1564080
الإتاحة: https://doi.org/10.1080/09553002.2019.1564080Test
http://hdl.handle.net/11571/1320766Test
http://www.tandfonline.com/loi/irab20Test
رقم الانضمام: edsbas.FFF17FD1
قاعدة البيانات: BASE